AltPep Corporation Revenue and Competitors

Seattle, WA USA

Location

$76M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AltPep Corporation's estimated annual revenue is currently $3.5M per year.(i)
  • AltPep Corporation's estimated revenue per employee is $77,500
  • AltPep Corporation's total funding is $76M.

Employee Data

  • AltPep Corporation has 45 Employees.(i)
  • AltPep Corporation grew their employee count by 5% last year.

AltPep Corporation's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
VP Business DevelopmentReveal Email/Phone
3
Director FinanceReveal Email/Phone
4
Acting Director, Regulatory AffairsReveal Email/Phone
5
Director FinanceReveal Email/Phone
6
Director QualityReveal Email/Phone
7
DirectorReveal Email/Phone
8
Chief Legal OfficerReveal Email/Phone
9
Chief Medical OfficerReveal Email/Phone
10
Chief Operating OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$3.3M4310%$101MN/A
#4
$5.7M3712%N/AN/A
#5
$7M4541%N/AN/A
#6
$1.7M22-8%N/AN/A
#7
$3.9M504%$10.1MN/A
#8
$1.9M12-73%N/AN/A
#9
$29.3M151-17%$148MN/A
#10
$2M1386%N/AN/A
Add Company

What Is AltPep Corporation?

AltPep develops early detection tools and disease-modifying treatments for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach. Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.

keywords:N/A

$76M

Total Funding

45

Number of Employees

$3.5M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AltPep Corporation News

2022-03-22 - In Brief This Week: Abbott, Labcorp, Pacific Biosciences ...

Laboratory Corporation of America last week disclosed in its Form 10-K that ... AltPep said this week that it has received US Food and Drug...

2022-03-22 - AltPep Receives FDA Breakthrough Device Designation for ...

SEATTLE--(BUSINESS WIRE)--AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.4M450%$116M
#2
$11.1M45-21%$91.1M
#3
$5M452%N/A
#4
$3.7M45N/AN/A
#5
$9M457%N/A